NodThera

Rezera (formerly NodThera)

Rezera develops oral NLRP3 inhibitors to treat patients with cardiovascular and neurologic diseases, specifically focusing on peripheral artery disease and neuroinflammation.

NeuroTherapia

This clinical-stage company develops oral small-molecule therapies targeting neuroinflammation for patients with Alzheimer's disease and other neurodegenerative disorders.

PsiThera

PsiThera develops oral small-molecule medicines for patients with immune and inflammatory diseases, using a physics-driven platform to target proteins traditionally requiring injections.

Forward Therapeutics

The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.

IFM Therapeutics

The company develops small molecule medicines targeting the innate immune system to treat patients with inflammatory diseases and cancer.

innovothera

This biotechnology company develops small-molecule therapies for fibrosis, inflammatory diseases, and cancer using an artificial intelligence drug discovery platform.

Therini Bio

The company develops fibrin-targeting monoclonal antibodies to treat patients with neurodegenerative and retinal diseases caused by vascular-mediated inflammation.

Augustine Therapeutics

This company develops small molecule inhibitors to treat patients with neuromuscular, neurodegenerative and cardio-metabolic diseases.